XML 22 R8.htm IDEA: XBRL DOCUMENT v3.21.4
Condensed Consolidated Statement Of Cash Flows - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2020
Oct. 31, 2021
Sep. 30, 2021
Oct. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Cash Flows from Operating Activities:            
Net loss $ (1,400)   $ (21,421,515)      
Adjustments to reconcile net loss to net cash used in operating activities:            
General and administrative expenses paid by related party under promissory note     1,000      
Gain on investments (net), dividends and interest, held in Trust Account     (98,658)      
Loss upon issuance of private placement warrants     14,062,000      
Offering costs associated with derivative warrant liabilities     710,745      
Change in fair value of derivative warrant liabilities     (705,000)      
Legal expenses deferred until business combination     2,361,156      
Changes in operating assets and liabilities:            
Prepaid expenses     (50,208)      
Accounts payable     74,281      
Accrued expenses 1,000   3,815,044      
Franchise tax payable 400   150,050      
Net cash used in operating activities 0   (3,462,261)      
Cash Flows from Investing Activities            
Cash deposited in Trust Account     (345,000,000)      
Net cash used in investing activities     (345,000,000)      
Cash Flows from Financing Activities:            
Proceeds from loans from related parties     362,292      
Repayment of loans from related parties     (1,116,142)      
Proceeds received from initial public offering, gross     345,000,000      
Proceeds received from private placement     8,900,000      
Offering costs paid     (6,969,070)      
Principal payment of convertible notes     (991,000)      
Net cash provided by financing activities     348,538,236      
Net increase in cash 0   75,975      
Cash - beginning of the period     0      
Cash - end of the period 0   75,975      
Supplemental disclosure of noncash activities:            
Offering costs included in accounts payable 10,000   39,194      
Offering costs included in accrued expenses 50,000   85,000      
Offering costs paid by related party under promissory note     439,100      
Prepaid expenses paid by related party under promissory note     425,000      
Reversal of accrued expenses     50,000      
Deferred underwriting commissions in connection with the initial public offering     12,075,000      
Value of Class A common stock subject to possible redemption     2,361,156      
Deferred offering costs paid by Sponsor under note payable 750          
Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock $ 25,000          
Planet Labs Inc [Member]            
Cash Flows from Operating Activities:            
Net loss   $ (91,159,000)   $ (89,605,000) $ (127,103,000) $ (123,714,000)
Adjustments to reconcile net loss to net cash used in operating activities:            
Depreciation and amortization   33,865,000   46,300,000 62,212,000 77,629,000
Stock-based compensation, net of capitalized cost of $526 and $957, respectively   12,619,000   11,089,000 14,012,000 5,071,000
Provision for doubtful accounts   140,000   1,001,000 823,000 649,000
Change in fair value of convertible notes and warrant liabilities   11,429,000   16,513,000 30,053,000 (207,000)
Debt extinguishment (gain) loss   0   (673,000) (673,000) 11,529,000
Deferred income taxes   406,000   121,000 (45,000) (399,000)
Amortization of debt discount and issuance costs   2,328,000   1,966,000 2,750,000 1,392,000
Changes in operating assets and liabilities:            
Accounts receivable   32,336,000   (17,512,000) (19,932,000) 8,959,000
Prepaid expenses and other assets   (12,860,000)   (1,321,000) 2,617,000 12,942,000
Accounts payable, accrued and other liabilities   2,061,000   (565,000) 11,033,000 3,071,000
Deferred revenue   (17,401,000)   (768,000) 14,433,000 (27,286,000)
Deferred hosting cost   6,759,000   6,802,000 7,971,000  
Deferred rent   (1,539,000)   (1,444,000) (2,223,000) (3,722,000)
Net cash used in operating activities   (21,016,000)   (28,096,000) (4,027,000) (33,687,000)
Cash Flows from Investing Activities            
Purchases of property and equipment   (6,051,000)   (20,845,000) (26,096,000) (16,665,000)
Capitalized internal-use software   (2,678,000)   (3,009,000) (4,030,000) (7,436,000)
Business acquisition, net of cash acquired           (2,457,000)
Other   (454,000)   (422,000) (674,000) (614,000)
Net cash used in investing activities   (9,183,000)   (24,276,000) (30,800,000) (27,172,000)
Cash Flows from Financing Activities:            
Proceeds from the exercise of common stock options   6,866,000   438,000 539,000 264,000
Proceeds from issuance of convertible preferred stock, net           10,000,000
Principal payment of long-term debt           (51,176,000)
Proceeds from issuance of debt and common stock warrants, net of issuance costs   0   14,862,000 14,862,000 49,640,000
Principal payment of convertible notes   0   (2,586,000) (2,586,000)  
Proceeds from the early exercise of common stock options   17,928,000   0    
Payments of deferred offering costs   (5,281,000)   0    
Proceeds from issuance of convertible notes and preferred stock warrant   0   71,125,000 71,125,000  
Net cash provided by financing activities   19,513,000   83,839,000 83,940,000 8,728,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash   (807,000)   250,000 (312,000) (38,000)
Net increase in cash   (11,493,000)   31,717,000 48,801,000 (52,169,000)
Cash - beginning of the period   76,540,000   27,739,000 27,739,000 79,908,000
Cash - end of the period   65,047,000   59,456,000 76,540,000 27,739,000
Supplemental disclosure of cash flow information            
Cash paid for interest   5,422,000   4,727,000 6,554,000 5,544,000
Cash paid for income tax   $ 672,000   447,000 1,084,000  
Supplemental disclosure of noncash activities:            
Convertible preferred stock issued for acquisition of business           14,772,000
Exchange of convertible notes           10,963,000
Accrued purchase of property and equipment     444,000 890,000 $ 522,000 $ 637,000
Deferred offering costs, accrued but not paid     $ 1,129,000 $ 0